WP
ABOS icon

Woodline Partners’s Acumen Pharmaceuticals ABOS Stock Holding History

Woodline Partners’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-426,172
Closed -$1.73M – 619
2023
Q1 		$1.73M Hold
426,172
– – 0.02% 432
2022
Q4 		$2.3M Sell
426,172
-5,986
-1% -$40.2K 0.03% 458
2022
Q3 		$4.33M Buy
432,158
+5,988
+1% +$34.3K 0.06% 328
2022
Q2 		$2M Sell
426,170
-75,066
-15% -$282K 0.03% 422
2022
Q1 		$1.96M Buy
501,236
+20,555
+4% +$112K 0.03% 385
2021
Q4 		$3.25M Buy
480,681
+11,887
+3% +$131K 0.05% 346
2021
Q3 		$6.97M Buy
+468,794
New +$7.8M 0.12% 213

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return